Glycopyrronium Bromide

한글명:Glycopyrronium Bromide

카스 번호51186-83-5

상품명:Glycopyrronium Bromide

CBNumberCB91270476

분자식C19H28NO3.Br

포뮬러 무게0

MOL 파일51186-83-5.mol

화학적 성질

녹는점	175℃
용해도	물에 잘 녹고, 에탄올(96%)에 잘 녹으며, 염화메틸렌에는 아주 약간 녹습니다.
InChI	InChI=1/C19H28NO3.BrH/c1-20(2)13-12-17(14-20)23-18(21)19(22,16-10-6-7-11-16)15-8-4-3-5-9-15;/h3-5,8-9,16-17,22H,6-7,10-14H2,1-2H3;1H/q+1;/p-1/t17-,19-;/s3
InChIKey	VPNYRYCIDCJBOM-SCHKGOGONA-M
SMILES	[N+]1(C)(C)CC[C@H](OC([C@](C2CCCC2)(O)C2=CC=CC=C2)=O)C1.[Br-] \|&1:5,8,r\|

위험 및 안전 성명

HS 번호

2933997500

Glycopyrronium Bromide 화학적 특성, 용도, 생산

개요
Glycopyrronium bromide or NVA 237 is a once-daily inhaled antimuscarinic bronchodilator newly approved by the European Commission for use in stable COPD. It is characterized by a quaternary ammonium structure, which reduces its oral bioavailability and, consequently, the systematic effects of any swallowed portion of the drug. Animal studies suggest that there are fewer cardiovascular effects compared to tiotropium because of the higher affinity to M3 versus M2 muscarinic receptors. Human studies showed fast onset of action, sustained bronchodilatation for 24 h, reduced dynamic hyperinflation of the lungs, and improved exercise tolerance. Glycopyrronium bromide in COPD airways clinical trial series (GLOW1–3) are the major clinical trials studying the efficacy and safety of glycopyrronium[1].
화학적 성질
White or almost white, crystalline powder.
용도
erythro-Glycopyrronium Bromide is used in preparation of diester containing compounds for treating hyperhidrosis.
Indications
Glycopyrronium bromide is indicated for use as a preoperative antimuscarinic to reduce salivary, tracheobronchial, and pharyngeal secretions; to reduce the volume and free acidity of gastric secretions, and to block cardiac vagal inhibitory reflexes during induction of anaesthesia and intubation when indicated. Glycopyrronium bromide may be used intraoperatively to counteract drug-induced or vagal traction reflexes with the associated arrhythmias. Glycopyrronium bromide protects against the peripheral muscarinic effects (e.g., bradycardia and excessive secretions) of cholinergic agents such as neostigmine and pyridostigmine given to reverse the neuromuscular blockade due to non-depolarising muscle relaxants.

Glycopyrronium Bromide 공급 업체

Send Inquriy